About the Authors
- Nuruddeen D. Lewis
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Lori A. Patnaude
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Josephine Pelletier
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Donald J. Souza
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Susan M. Lukas
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- F. James King
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Jonathan D. Hill
-
Affiliation Research Networking, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Dimitria E. Stefanopoulos
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Kelli Ryan
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Sudha Desai
-
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Donna Skow
-
Affiliation Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Stefan G. Kauschke
-
Affiliation CardioMetabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Biberach, Germany
- Andre Broermann
-
Affiliation CardioMetabolic Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Biberach, Germany
- Daniel Kuzmich
-
Affiliation Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Christian Harcken
-
Affiliation Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Eugene R. Hickey
-
Affiliation Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
- Louise K. Modis
-
* E-mail: Louise-kelly.modis@boehringer-ingelheim.com
Affiliation Departments of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgebury, Connecticut, United States of America
Competing Interests
All authors were employees of Boehringer Ingelheim Pharmaceuticals, whose company funded this study, when the work was performed. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NDL LAP DS SML JDH KR DJS LKM. Performed the experiments: NDL LAP JP SML DES KR SD DS. Analyzed the data: NDL LAP JP DS SML FJK JDH DES KR DJS. Contributed reagents/materials/analysis tools: SGK AB DK CH ERH. Wrote the paper: LKM NDL FJK LAP.